Pharmafile Logo

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market.
Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Mere View Barn, Park Lane, Pickmere, Knutsford, WA16 0LG, UK
+44 1565 733 772

 Latest Content from PMHub 

Blending qual and quant – the benefits of a hybrid approach

White Papers and Resources | September 6, 2017 | Inizio

My colleague Chris Gaj and I recently conducted a video dialogue on the topic of hybrid qual/quant methods in which we discussed why clients often want to blend the two, and the...

Multi-level Segmentation Solution

White Papers and Resources | September 6, 2017 | Inizio

Our client has an established product for multiple indications. They wanted to create a HCP segmentation typing tool which could be implemented in-field to help classify physicians across two different...

Global health care specialists from coast to coast

White Papers and Resources | September 6, 2017 | Inizio

Published in Quirk's Faces of Marketing Research August 2017

Demand assessment research video

White Papers and Resources | September 6, 2017 | Inizio

Head of Business Analytics Tom Nolte and Associate Director Will Tolley discuss demand assessment research – the various techniques and when in a product's stage of development a demand assessment...

Building a creative marketing consultancy: how we’ve transitioned into a full service global team

In this Q&A, James Atherton, Vice President and Managing Consultant at our New York office, reveals how our NYC and London offices work together and why having a creative services...

Can we ‘outsmart’ smartphone addiction by using it to develop effective health apps?

Are you guilty of repeatedly checking your phone 24/7? Our new blog explores what makes them so addictive and how understanding this may help us develop more effective health apps.

Lucid welcome their graduate Customer Experience Managers

Lucid has had an incredibly busy summer attending recruitment fairs all across the country to find the finest graduate talent for their Futures Executive Programme. As part of its graduate...

The science of experience planning in pharma media

Our digital lead, Richard Springham, looks at how the principles of behavioural science and experience planning are used in best practice pharma media planning.

Who will be the new disrupter of HCP media

Our digital lead, Richard Springham, looks at the move of the tech behemoths and the impact on HCP media.

Why I think rare disease companies are more patient-centric

Guest blogger Kamlesh Sheth believes companies that specialise in rare disease tend to be more patient-centric.